{
  "docId": "019dd923-622c-750b-8b99-9ee2a1e788fb",
  "docSlug": "1233d0b05ad9",
  "documentTitle": "PROCEPT BioRobotics Corporation (PRCT)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-01-16 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 12,
  "pageCount": 100,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "villain_critique",
  "function": "expose_contradiction",
  "density": "sparse",
  "nDataPoints": null,
  "notes": "The slide uses a direct comparison between the company's 'FOR ALL PROSTATES' marketing claim and expert testimony to frame the company's growth narrative as fraudulent.",
  "elementsJson": [
    "headline_text",
    "callout_box",
    "screenshot",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": null,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-9ee2a1e788fb/12",
  "deckHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb#slide-12",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "In contrast to the Procept pitch, many urologists fundamentally disagree that Aquablation is well-suited to treat all BPH patients.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-ee35-7258-b4d8-f64bfabcda3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“Every company wants to make it like ‘we have the thing that treats the full spectrum’, and that does not exist. So if you ever have someone telling you that they have something that treats all prostate sizes, that is not correct...” — Private Practice Urologist, Dec 2024",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-ee35-7258-b4d8-f8cd74db1ea8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 20,
      "from": 11,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "7ffce90f-7469-4962-8ccc-f8b71e2baf08",
      "evidence": "Analysis of the BPH treatment market and the trade-offs of BPH treatments",
      "position": 0,
      "objective": "Highlighting the risks and limitations of Procept's Aquablation procedure",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}